# GeneDx Holdings Corp. (WGS) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from GeneDx Holdings Corp.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/WGS/mda/fy2025/): filed 2026-02-23; accession 0001818331-26-000015 (https://www.sec.gov/Archives/edgar/data/1818331/000181833126000015/wgs-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/WGS/mda/fy2024/): filed 2025-02-20; accession 0001818331-25-000021 (https://www.sec.gov/Archives/edgar/data/1818331/000181833125000021/wgs-20241231.htm)
- [FY 2023 MD&A](/company/WGS/mda/fy2023/): filed 2024-02-23; accession 0001818331-24-000008 (https://www.sec.gov/Archives/edgar/data/1818331/000181833124000008/wgs-20231231.htm)
- [FY 2022 MD&A](/company/WGS/mda/fy2022/): filed 2023-03-16; accession 0001818331-23-000024 (https://www.sec.gov/Archives/edgar/data/1818331/000181833123000024/wgs-20221231.htm)
- [FY 2021 MD&A](/company/WGS/mda/fy2021/): filed 2022-03-14; accession 0001818331-22-000037 (https://www.sec.gov/Archives/edgar/data/1818331/000181833122000037/cmlf-20211231.htm)

Back to /company/WGS/